Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs.
Usama QamarFarhan NaeemMuhammad Talha MaqsoodMaleeka Zamurad KhanZeeshan ImtiazFatima SaeedNeelesh GuptaFnu Zafarullah BrohiCelestine MkpoziYasar SattarPublished in: European journal of clinical pharmacology (2024)
Brief DAPT followed by ticagrelor monotherapy is superior to a 12-month DAPT in offering a net clinical advantage in ACS patients following PCI.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- chronic kidney disease
- coronary artery disease
- st segment elevation myocardial infarction
- prognostic factors
- acute myocardial infarction
- peritoneal dialysis
- clinical trial
- randomized controlled trial
- coronary artery bypass grafting
- patient reported outcomes
- study protocol